Viewing Study NCT02102594


Ignite Creation Date: 2025-12-25 @ 1:43 AM
Ignite Modification Date: 2026-04-09 @ 7:27 AM
Study NCT ID: NCT02102594
Status: TERMINATED
Last Update Posted: 2019-12-03
First Post: 2014-03-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Therapy of Antibody-mediated Autoimmune Diseases by Bortezomib (TAVAB)
Sponsor: Charite University, Berlin, Germany
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module